WUXI BIO (02269): Miao Jingwen appointed as non-executive director.
Wu Yibing, Ph.D., has resigned as of November 20, 2024, in an announcement from WuXi Biologics (02269).
WUXI BIO (02269) announces that, effective from November 20, 2024, Dr. Wu Yibing has resigned as a non-executive director and member of the Board's decision-making committee to dedicate more time to other personal matters. Ms. Miao Jingwen has been appointed as a non-executive director and member of the decision-making committee.
Related Articles

Guolian Minsheng Securities: The probability of the Federal Reserve continuing to cut interest rates this year is still not low.

New stock news | Green Cloud Software submits application to Hong Kong Stock Exchange as the leading digital service provider for China's hospitality industry.

New stocks news | Green Cloud Software submits application to Hong Kong Stock Exchange
Guolian Minsheng Securities: The probability of the Federal Reserve continuing to cut interest rates this year is still not low.

New stock news | Green Cloud Software submits application to Hong Kong Stock Exchange as the leading digital service provider for China's hospitality industry.

New stocks news | Green Cloud Software submits application to Hong Kong Stock Exchange

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


